Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways.
Quagliariello V, Passariello M, Di Mauro A, Cipullo C, Paccone A, Barbieri A, Palma G, Luciano A, Buccolo S, Bisceglia I, Canale ML, Gallucci G, Inno A, De Lorenzo C, Maurea N. Quagliariello V, et al. Among authors: de lorenzo c. Front Cardiovasc Med. 2023 Jan 19;10:1129873. doi: 10.3389/fcvm.2023.1129873. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36742077 Free PMC article.
Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors.
Fedele C, Riccio G, Coppola C, Barbieri A, Monti MG, Arra C, Tocchetti CG, D'Alessio G, Maurea N, De Lorenzo C. Fedele C, et al. Among authors: de lorenzo c. Breast Cancer Res Treat. 2012 Jun;133(2):511-21. doi: 10.1007/s10549-011-1783-9. Epub 2011 Sep 27. Breast Cancer Res Treat. 2012. PMID: 21947749
Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.
Maurea N, Coppola C, Piscopo G, Galletta F, Riccio G, Esposito E, De Lorenzo C, De Laurentiis M, Spallarossa P, Mercuro G. Maurea N, et al. Among authors: de lorenzo c, de laurentiis m. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S19-26. doi: 10.2459/JCM.0000000000000377. J Cardiovasc Med (Hagerstown). 2016. PMID: 27183521 Review.
Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.
Maurea N, Coppola C, Piscopo G, Galletta F, Riccio G, Esposito E, De Lorenzo C, De Laurentiis M, Spallarossa P, Mercuro G. Maurea N, et al. Among authors: de lorenzo c, de laurentiis m. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection:e19-e26. doi: 10.2459/JCM.0000000000000377. J Cardiovasc Med (Hagerstown). 2016. PMID: 27755239 Review.
234 results